Epstein-Barr virus in action in vivo.
Rickinson
A B
AB
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D015870:Gene Expression; D004854:Herpesvirus 4, Human / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D016867:Immunocompromised Host; D008228:Lymphoma, Non-Hodgkin / Q000378:metabolism / Q000821:virology*; D008232:Lymphoproliferative Disorders / Q000378:metabolism / Q000821:virology*; D016328:NF-kappa B / Q000378:metabolism; D011506:Proteins / Q000502:physiology; D018124:Receptors, Tumor Necrosis Factor; D015398:Signal Transduction; D014180:Transplantation / Q000009:adverse effects; D014763:Viral Matrix Proteins / Q000502:physiology*
C037662:EBV-associated membrane antigen, Epstein-Barr virus; D016328:NF-kappa B; D011506:Proteins; D018124:Receptors, Tumor Necrosis Factor; D014763:Viral Matrix Proteins